IGF-1LR3 IG1 1mg*10vials

IGF-1 LR3 IG1 1mg x 10 Vials

Product Overview

IGF-1 LR3 IG1 is a high-concentration long-acting recombinant IGF-1 analog research peptide, serving as an upgraded version of the standard IG01 specification. It retains the classic optimized long-acting R3-modified molecular structure, featuring 13 N-terminal amino acid extensions and site-specific amino acid substitutions, supporting extended half-life and IGFBP-mediated inactivation resistance research. Compared to the traditional 0.1mg specification, the concentration per vial of IG1 is increased tenfold, supporting target binding saturation and PI3K/Akt/mTOR signaling pathway activation research, exceeding the efficacy range of standard low-dose IGF-1 LR3 products. This product supports growth hormone-dependent endogenous regulation limitation related studies, employing a concentrated formula designed for high-intensity cell remodeling research, high-load tissue repair modeling, extreme metabolic intervention, and high-threshold peptide synergistic effect validation. It serves as an efficient core research material for advanced cell proliferation, bone metabolism, insulin resistance intervention, and deep anti-aging mechanism preclinical studies.

Core Research Functions

Downstream Core Signaling Pathway Saturation: Supports downstream core signaling pathway saturation research, somatic cell proliferation activation, high-density lean tissue anabolism, glucose metabolic remodeling, and anti-apoptotic protection studies.

Myocyte Proliferation and Severe Myofiber Damage Repair: Supports myocyte proliferation promotion and severe myofiber damage repair research, and high-load lean tissue proliferation model construction studies.

Peripheral Insulin Signal Sensitivity Optimization: Supports peripheral insulin signal sensitivity optimization research and severe refractory insulin resistance metabolic model intervention studies.

Cellular Oxidative Stress and Deep Aging Inhibition: Supports cellular oxidative stress and deep aging inhibition research, and multi-tissue degenerative aging process delay studies.

Osteoblast Proliferation and Bone Mineralization Promotion: Supports osteoblast proliferation and bone mineralization promotion research, and high-standard bone metabolism and growth regulation research.

H-Series Growth Hormone Peptide Synergistic Interaction: Supports H-series growth hormone peptide synergistic interaction research, growth hormone and insulin-like growth factor-1 axis positive feedback loop construction studies, and systemic anabolic metabolism and metabolic remodeling efficacy research.

Compared to traditional low-dose IG01, 1mg IG1 provides 10 times the intervention intensity, faster phenotypic response, and more durable metabolic regulation research capabilities. The 1mg high-activity specification supports experimental differentiation and stable long-term efficacy research, suitable for high-dose gradient threshold screening, extreme physiological intervention models, and highly complex compound peptide research, providing high-discrimination reproducible data for advanced pharmacology and cell biology mechanism exploration research.

Core Product Advantages

Classic LR3 Long-Acting Stable Structure: Inherits mature Long R3 molecular optimization technology, supporting endogenous IGFBP1 and IGFBP3 protein binding and inactivation resistance research. It maintains free biological activity research capabilities both in vitro and in vivo, with extended half-life, supporting natural IGF-1 short half-life and rapid decay related defect research.

1mg High-Concentration Upgraded Specification: The concentration is 10 times that of the standard 0.1mg product, supporting pathway saturation activation and intervention intensity research. It provides research capabilities for high-threshold extreme modeling scenarios that exceed low-dose specification efficacy ranges.

Independent Direct Pathway Activation: Supports pituitary growth hormone secretion function independence related studies, directly supplementing active IGF-1, supporting downstream anabolic metabolism, glucose metabolism, and cell survival pathway rapid triggering research. It supports growth hormone monotherapy studies indirect efficacy lag related research, achieving efficient physiological remodeling research capabilities.

High-Purity Activity-Locking Process: Utilizes upgraded multi-stage gradient purification and full-vacuum freeze-drying technology, preserving peptide activity with minimal foreign protein interference, providing high-purity experimental variables and supporting accuracy and reproducibility of advanced extreme research conclusions.

Advanced Aseptic Integrated Packaging: High-standard aseptic packaging of 10 vials per pack. Each batch undergoes rigorous full-range HPLC purity testing and is accompanied by a complete Certificate of Analysis (COA). With long-term stable activity maintenance, it is suitable for advanced laboratory research, key scientific research projects, and customized bulk procurement.

Specifications and Quality Control

Format: Lyophilized powder, 1mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).